CN112133381A - Analysis method and system for drug research and development by using intelligent medicine database - Google Patents
Analysis method and system for drug research and development by using intelligent medicine database Download PDFInfo
- Publication number
- CN112133381A CN112133381A CN202011020973.3A CN202011020973A CN112133381A CN 112133381 A CN112133381 A CN 112133381A CN 202011020973 A CN202011020973 A CN 202011020973A CN 112133381 A CN112133381 A CN 112133381A
- Authority
- CN
- China
- Prior art keywords
- database
- medicine
- stress
- drug
- electronic tag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 411
- 229940079593 drug Drugs 0.000 title claims abstract description 185
- 238000004458 analytical method Methods 0.000 title claims abstract description 34
- 238000012827 research and development Methods 0.000 title abstract description 16
- 230000001960 triggered effect Effects 0.000 claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000003213 activating effect Effects 0.000 claims abstract description 5
- 238000009509 drug development Methods 0.000 claims description 11
- 230000007721 medicinal effect Effects 0.000 claims description 4
- 238000013508 migration Methods 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 abstract description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003938 response to stress Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/50—Molecular design, e.g. of drugs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Computing Systems (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The application discloses an analysis method and a system for drug research and development by using an intelligent drug database, wherein the method comprises the following steps: s1, presetting a target stress rule; s2, establishing a stress model, and receiving the electronic target and the cloud database through the stress model; activating the electronic target and the cloud database to obtain a dynamic target and a dynamic drug stimulated scene; s3, according to the target stress rule, enabling the dynamic target to swim to trigger the dynamic drug stimulated scene; the electronic tag is used for marking the triggered medicine and medicinal application data in the dynamic medicine stimulated scene; and S4, acquiring the triggered electronic tag, extracting corresponding medicine and medicinal use data and sending the corresponding medicine and medicinal use data to a medicine research and development center. According to the invention, the targeted stress medicament or medicinal use data is obtained through the stress reaction environment, the stress screening time of the targeted medicament is greatly reduced, and the medicament research and development speed is improved.
Description
Technical Field
The application relates to the technical field of drug development, in particular to an analysis method and system for drug research and development by using an intelligent drug database.
Background
Medicine research and development is a standing engineering activity with long cycle and wide drug-related range, and is limited by the need of converging factors such as market drugs, patient demand analysis, capital cost and the like.
In the process of medicine research and development, for a certain class of diseases, a medicine analysis technical thought for the research and development needs to be established, and upgrading needs to be carried out on the existing medicine plan.
The target corresponding to a certain disease or drug is wide in application range, and cannot be extracted and analyzed one by one, so that if the target is singly tested for drug property, the time consumption is too long, and the period is longer.
Therefore, it is necessary to shorten the analysis period of drug or drug use screening, increase the speed of testing the drug property response of the target to the test drug, and improve the drug auxiliary research and development.
Disclosure of Invention
The present application is directed to an analysis method and system for drug development using an intelligent medical database to solve the current problems.
In order to achieve the above object, the present application provides the following techniques:
the invention provides an analysis method for drug research and development by using an intelligent drug database, which comprises the following steps:
s1, presetting a target stress rule;
setting an electronic target and setting a cloud database comprising medicine and medicinal use data through an electronic tag;
s2, establishing a stress model, and receiving the electronic target and the cloud database through the stress model;
activating the electronic target and the cloud database to obtain a dynamic target and a dynamic drug stimulated scene;
s3, according to the target stress rule, enabling the dynamic target to swim to trigger the dynamic drug stimulated scene;
the electronic tag is used for marking the triggered medicine and medicinal application data in the dynamic medicine stimulated scene;
and S4, acquiring the triggered electronic tag, extracting corresponding medicine and medicinal use data and sending the corresponding medicine and medicinal use data to a medicine research and development center.
Preferably, the setting of the cloud database including the data of the drug and the pharmaceutical use by the electronic tag includes:
establishing a first-class drug database: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
establishing a second type drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
Preferably, the establishing a stress model, and the receiving the electronic target and the cloud database through the stress model, include:
building a stress environment based on the preset target stress rule;
setting a reactor space for accommodating the stress environment;
and establishing a stress model port corresponding to the reactor space.
Preferably, the causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule includes:
throwing the triggered medicine and medicinal use data electronic tag in the dynamic medicine excited scene into the reactor space through the stress model port;
delivering the dynamic target through the stress model port, wherein the dynamic target triggers a drug with drug property reaction and a medical purpose data electronic tag;
the label triggers the drug and medicinal use data electronic label with drug property reaction.
Preferably, the setting of the cloud database including the data of the medicament and the medicinal use by the electronic tag further includes:
establishing a historical medication database: the historical medication information database stores historical medication information data of the first-class medicament database and/or the second-class medicament database, and is a cloud database which electronically marks the historical medication information data in the cloud database by adopting an electronic tag;
establishing a medical condition medication database: the medical condition medication information data of the first type of medicine database and/or the second type of medicine database are stored in the medical condition database, and the medical condition medication database is a cloud database which electronically marks the medical condition medication information data in the cloud database by adopting an electronic tag.
The second aspect of the present invention provides an analysis system for drug development using an intelligent medicine database, which includes a targeted stress preparation module, a stress model module, a stress electronic tag acquisition module, and an analysis module, wherein:
targeted stress preparation module: for presetting a targeted stress rule; and a cloud database for setting electronic targets and setting data including drugs and medicinal use data by the electronic tags;
a stress model module: the cloud database is used for establishing a stress model, and receiving the electronic target and the cloud database through the stress model; the electronic target and the cloud database are activated to obtain a dynamic target and a dynamic drug stimulated scene;
a stress electronic tag acquisition module: for causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule; and an electronic tag for marking the triggered drug and medicinal use data in the dynamic drug stimulated scene;
an analysis module: the electronic tag is used for acquiring the triggered electronic tag, extracting corresponding medicine and medicinal application data and sending the corresponding medicine and medicinal application data to a medicine research and development center.
Preferably, the cloud database includes:
first-class drug databases: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
second-class drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
Preferably, the stress model module comprises:
a stress environment building platform: the method is used for building a stress environment based on the preset target stress rule;
stress reactor space: for containing the stressful environment;
stress model port: and the electronic tag is used for receiving the triggered medicine and medicinal application data in the dynamic medicine excited scene and putting the electronic tag into a stress reactor space.
Preferably, the stress electronic tag obtaining module includes:
electronic tags puts in module: the electronic label is used for throwing the triggered medicine and medicinal use data in the dynamic medicine excited scene into the reactor space through the stress model port; and delivering the dynamic target to the reactor space through the stress model port, wherein the dynamic target triggers a medicine and medicinal use data electronic tag with medicine property reaction;
a marking module: the data electronic tag is used for marking and triggering medicines with medicinal property reactions and medicinal application data.
Preferably, the cloud database further includes:
historical drug use database: the historical medication information database stores historical medication information data of the first-class medicament database and/or the second-class medicament database, and is a cloud database which electronically marks the historical medication information data in the cloud database by adopting an electronic tag;
medical condition medication database: the medical condition medication information data of the first type of medicine database and/or the second type of medicine database are stored in the medical condition database, and the medical condition medication database is a cloud database which electronically marks the medical condition medication information data in the cloud database by adopting an electronic tag.
Compared with the prior art, this application can bring following technological effect:
the technical principle of the invention is that a stress reaction environment is set, and after the medicine and medicinal use data are marked by an electronic tag, the medicine and medicinal use data are put into a dynamic space to form a dynamic medicine stimulated scene; stress activation is carried out on an electronic target developed by drug analysis, a computer program is adopted for simulation control, a dynamic target is formed, the dynamic target is put into a dynamic drug stimulated scene, and the drug or medicinal use data of the dynamic drug stimulated scene in the dynamic drug stimulated scene can be stimulated under a preset target stress rule; when the fact that the drug or the medicinal use data have stress reaction on the dynamic target is detected, the electronic tag of the drug or the medicinal use data is marked, and finally the database is cleaned, and the data with the marked labels are left, so that the corresponding targeted stress drug or medicinal use data are obtained, the stress screening time of the targeted drug is greatly reduced, and the drug research and development speed is improved.
Drawings
The accompanying drawings, which are incorporated in and constitute a part of this application, serve to provide a further understanding of the application and to enable other features, objects, and advantages of the application to be more apparent. The drawings and their description illustrate the embodiments of the invention and do not limit it. In the drawings:
FIG. 1 is a schematic diagram of the steps of the present invention for performing an analysis method for drug development using an intelligent medical database;
FIG. 2 is a schematic diagram of the steps for establishing a stress model according to the present invention;
FIG. 3 is a schematic diagram of an embodiment of an analysis system for drug development using an intelligent medical database according to the present invention;
fig. 4 is a schematic structural diagram of another embodiment of the analysis system for drug development using an intelligent medical database according to the present invention.
Detailed Description
In order to make the technical solutions better understood by those skilled in the art, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the drawings in the embodiments of the present application, and it is obvious that the described embodiments are only partial embodiments of the present application, but not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
It should be noted that the terms "first," "second," and the like in the description and claims of this application and in the drawings described above are used for distinguishing between similar elements and not necessarily for describing a particular sequential or chronological order. It should be understood that the data so used may be interchanged under appropriate circumstances such that embodiments of the application described herein may be used. Furthermore, the terms "comprises," "comprising," and "having," and any variations thereof, are intended to cover a non-exclusive inclusion, such that a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed, but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
In this application, the terms "upper", "lower", "left", "right", "front", "rear", "top", "bottom", "inner", "outer", "middle", "vertical", "horizontal", "lateral", "longitudinal", and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings. These terms are used primarily to better describe the present application and its embodiments, and are not used to limit the indicated devices, elements or components to a particular orientation or to be constructed and operated in a particular orientation.
Moreover, some of the above terms may be used to indicate other meanings besides the orientation or positional relationship, for example, the term "on" may also be used to indicate some kind of attachment or connection relationship in some cases. The specific meaning of these terms in this application will be understood by those of ordinary skill in the art as appropriate.
In addition, the term "plurality" shall mean two as well as more than two.
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present application will be described in detail below with reference to the embodiments with reference to the attached drawings.
Example 1
The technical principle of the invention is that a stress reaction environment is set, and after the medicine and medicinal use data are marked by an electronic tag, the medicine and medicinal use data are put into a dynamic space to form a dynamic medicine stimulated scene;
secondly, stress activation is carried out on an electronic target researched and developed by drug analysis, a computer program is adopted for simulation control, a dynamic target is formed, the dynamic target is put into a dynamic drug stimulated scene, and the drug or medicinal use data of the dynamic drug stimulated scene in the dynamic drug stimulated scene can be stimulated under a preset target stress rule;
when the fact that the drug or the medicinal use data have stress reaction on the dynamic target is detected, the electronic tag of the drug or the medicinal use data is marked, and finally the database is cleaned, and the data with the marked mark is left, so that the corresponding targeted stress drug or medicinal use data is obtained.
Therefore, the stress screening time of the targeted drug can be greatly reduced, and the drug research and development speed is improved.
As shown in the attached figure 1 of the drawings,
the invention provides an analysis method for drug research and development by using an intelligent drug database, which comprises the following steps:
s1, presetting a target stress rule;
setting an electronic target and setting a cloud database comprising medicine and medicinal use data through an electronic tag;
the target stress rule sets the drug property of the drug according to a target selected by drug research and development, for example, a certain type of cold virus is selected as the target, drug property analysis is carried out on the drug with drug property stress response to the virus, the drug property analysis result is set as the stress rule, and when the dynamic target is put into a dynamic drug stimulated scene, the drug and medical use data are automatically identified under the action of the target stress rule.
Firstly, a cloud database including medicine and medicinal use data needs to be set by an electronic tag, namely the cloud database stores the medicine and medicinal use data, but each medicine and medicinal use data is set by the electronic tag, so that later-stage identification marks are facilitated.
S2, establishing a stress model, and receiving the electronic target and the cloud database through the stress model;
the stress model is a cloud database training model established according to a targeted stress rule, the electronic target and the cloud database are received through the stress model, and dynamic identification and marking are sequentially carried out;
activating the electronic target and the cloud database to obtain a dynamic target and a dynamic drug stimulated scene;
and in the stress model, a dynamic simulation scene is provided, the electronic target and the cloud database are activated to obtain a dynamic target and a dynamic drug stimulated scene, and the dynamic target moves in the dynamic drug stimulated scene to perform drug property identification marking of stress reaction.
S3, according to the target stress rule, enabling the dynamic target to swim to trigger the dynamic drug stimulated scene;
under the guidance of a targeted stress rule, the dynamic target walks in a simulation space where the dynamic drug stimulated scene is located, and can trigger an electronic tag containing drugs and medicinal application data which generate stress drug property reaction with the targeted target; at this time, the process of the present invention,
the electronic tag is used for marking the triggered medicine and medicinal application data in the dynamic medicine stimulated scene;
the medicine and medicinal use data which generate medicine property stress response to the dynamic target are identified and marked, and the medicine and medicinal use data which do not react are not marked, so that the oriented medicine and medicinal use data are obtained, the research and development analysis of the medicine of the target are facilitated, and the analysis efficiency is accelerated.
And S4, acquiring the triggered electronic tag, extracting corresponding medicine and medicinal use data and sending the corresponding medicine and medicinal use data to a medicine research and development center.
After marking, the triggered electronic tags are collected, corresponding medicine and medicinal use data are extracted and sent to a medicine research and development center, the medicine research and development center can quickly acquire the medicine and medicinal use data for generating medicine property stress response to the targets, and historical medicine basic medicine properties are not required to be consulted and analyzed in a long time.
Preferably, the setting of the cloud database including the data of the drug and the pharmaceutical use by the electronic tag includes:
establishing a first-class drug database: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
establishing a second type drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
For the medicine of the target test, the invention comprehensively sets a cloud database, and adopts the cloud big data technology of traditional Chinese medicine and western medicine respectively.
The cloud big data information database is utilized to respectively set a traditional Chinese medicine database and a western medicine database:
the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal application data in the cloud database by adopting an electronic tag.
The traditional Chinese medicine and western medicine databases are marked by electronic tags, so that corresponding stress medicines including corresponding medicine use data can be conveniently marked during stress reaction.
Preferably, the establishing a stress model, and the receiving the electronic target and the cloud database through the stress model, include:
building a stress environment based on the preset target stress rule;
setting a reactor space for accommodating the stress environment;
and establishing a stress model port corresponding to the reactor space.
As shown in fig. 2, the stress model is constructed based on an analog simulation software platform, a target stress rule is preset in advance, and a stress environment is constructed; secondly, setting a reactor space for accommodating the stress environment through simulation software; and establishing a stress model port corresponding to the reactor space in simulation software for inputting the medicine and medicinal use data of the cloud database.
Preferably, the causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule includes:
throwing the triggered medicine and medicinal use data electronic tag in the dynamic medicine excited scene into the reactor space through the stress model port;
after the simulation analysis software is constructed, the drugs and the medical application data electronic tags triggered in the dynamic drug stimulated scene can be put into the reactor space through the stress model port for dynamic simulation;
secondly, the dynamic target is thrown through the stress model port, and the dynamic target triggers the medicine with medicine property reaction and the medical purpose data electronic tag;
the label triggers the drug and medicinal use data electronic label with drug property reaction.
And (4) performing data cleaning on the software platform, leaving a stressful label, and transmitting the label to a research and development center through a cloud server after intercepting.
As shown in fig. 3, a second aspect of the present invention provides an analysis system for drug development using an intelligent medicine database, which includes a targeted stress preparation module, a stress model module, a stress electronic tag acquisition module, and an analysis module, wherein:
targeted stress preparation module: for presetting a targeted stress rule; and a cloud database for setting electronic targets and setting data including drugs and medicinal use data by the electronic tags;
a stress model module: the cloud database is used for establishing a stress model, and receiving the electronic target and the cloud database through the stress model; the electronic target and the cloud database are activated to obtain a dynamic target and a dynamic drug stimulated scene;
a stress electronic tag acquisition module: for causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule; and an electronic tag for marking the triggered drug and medicinal use data in the dynamic drug stimulated scene;
an analysis module: the electronic tag is used for acquiring the triggered electronic tag, extracting corresponding medicine and medicinal application data and sending the corresponding medicine and medicinal application data to a medicine research and development center.
An analysis system for drug development using an intelligent drug database builds the modules under stress rules based on simulation software.
Preferably, the cloud database includes:
first-class drug databases: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
second-class drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
Preferably, the stress model module comprises:
a stress environment building platform: the method is used for building a stress environment based on the preset target stress rule;
stress reactor space: for containing the stressful environment;
stress model port: and the electronic tag is used for receiving the triggered medicine and medicinal application data in the dynamic medicine excited scene and putting the electronic tag into a stress reactor space.
Preferably, the stress electronic tag obtaining module includes:
electronic tags puts in module: the electronic label is used for throwing the triggered medicine and medicinal use data in the dynamic medicine excited scene into the reactor space through the stress model port; and delivering the dynamic target to the reactor space through the stress model port, wherein the dynamic target triggers a medicine and medicinal use data electronic tag with medicine property reaction;
a marking module: the data electronic tag is used for marking and triggering medicines with medicinal property reactions and medicinal application data.
Example 2
The invention provides an analysis method for drug research and development by using an intelligent drug database, which comprises the following steps:
s1, presetting a target stress rule;
setting an electronic target and setting a cloud database comprising medicine and medicinal use data through an electronic tag;
s2, establishing a stress model, and receiving the electronic target and the cloud database through the stress model;
activating the electronic target and the cloud database to obtain a dynamic target and a dynamic drug stimulated scene;
s3, according to the target stress rule, enabling the dynamic target to swim to trigger the dynamic drug stimulated scene;
the electronic tag is used for marking the triggered medicine and medicinal application data in the dynamic medicine stimulated scene;
and S4, acquiring the triggered electronic tag, extracting corresponding medicine and medicinal use data and sending the corresponding medicine and medicinal use data to a medicine research and development center.
Preferably, the setting of the cloud database including the data of the drug and the pharmaceutical use by the electronic tag includes:
establishing a first-class drug database: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
establishing a second type drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
Preferably, the establishing a stress model, and the receiving the electronic target and the cloud database through the stress model, include:
building a stress environment based on the preset target stress rule;
setting a reactor space for accommodating the stress environment;
and establishing a stress model port corresponding to the reactor space.
Preferably, the causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule includes:
throwing the triggered medicine and medicinal use data electronic tag in the dynamic medicine excited scene into the reactor space through the stress model port;
delivering the dynamic target through the stress model port, wherein the dynamic target triggers a drug with drug property reaction and a medical purpose data electronic tag;
the label triggers the drug and medicinal use data electronic label with drug property reaction.
Based on the implementation and application of the embodiment 1, the invention is additionally provided with a historical medication and medical condition database, and the target is screened and marked by matching Chinese and western medicines.
As shown in fig. 4, the historical administration database is used for setting historical data of administration to a target through an electronic tag for the set target, identifying and marking administration data of treatment control on the target in the past, and rapidly acquiring the past treatment administration data.
The medical condition medication database is used for looking up the medical condition characteristics of the patients carrying the targets or having the targets or using the targets in the past aiming at the targets, the medication data aiming at the condition characteristics are screened and identified through the condition characteristics, the cloud database can mark the diseases which have been subjected to the conditions in the past, and the accuracy of the identification marks of the targets can be enhanced by combining the two data during screening.
Preferably, the setting of the cloud database including the data of the medicament and the medicinal use by the electronic tag further includes:
establishing a historical medication database: the historical medication information database stores historical medication information data of the first-class medicament database and/or the second-class medicament database, and is a cloud database which electronically marks the historical medication information data in the cloud database by adopting an electronic tag;
establishing a medical condition medication database: the medical condition medication information data of the first type of medicine database and/or the second type of medicine database are stored in the medical condition database, and the medical condition medication database is a cloud database which electronically marks the medical condition medication information data in the cloud database by adopting an electronic tag.
Similarly, the second aspect of the present invention provides an analysis system for drug development using an intelligent medical database, which includes a targeted stress preparation module, a stress model module, a stress electronic tag acquisition module, and an analysis module, wherein:
targeted stress preparation module: for presetting a targeted stress rule; and a cloud database for setting electronic targets and setting data including drugs and medicinal use data by the electronic tags;
a stress model module: the cloud database is used for establishing a stress model, and receiving the electronic target and the cloud database through the stress model; the electronic target and the cloud database are activated to obtain a dynamic target and a dynamic drug stimulated scene;
a stress electronic tag acquisition module: for causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule; and an electronic tag for marking the triggered drug and medicinal use data in the dynamic drug stimulated scene;
an analysis module: the electronic tag is used for acquiring the triggered electronic tag, extracting corresponding medicine and medicinal application data and sending the corresponding medicine and medicinal application data to a medicine research and development center.
Preferably, the cloud database includes:
first-class drug databases: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
second-class drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
Preferably, the stress model module comprises:
a stress environment building platform: the method is used for building a stress environment based on the preset target stress rule;
stress reactor space: for containing the stressful environment;
stress model port: and the electronic tag is used for receiving the triggered medicine and medicinal application data in the dynamic medicine excited scene and putting the electronic tag into a stress reactor space.
Preferably, the stress electronic tag obtaining module includes:
electronic tags puts in module: the electronic label is used for throwing the triggered medicine and medicinal use data in the dynamic medicine excited scene into the reactor space through the stress model port; and delivering the dynamic target to the reactor space through the stress model port, wherein the dynamic target triggers a medicine and medicinal use data electronic tag with medicine property reaction;
a marking module: the data electronic tag is used for marking and triggering medicines with medicinal property reactions and medicinal application data.
Preferably, the cloud database further includes:
historical drug use database: the historical medication information database stores historical medication information data of the first-class medicament database and/or the second-class medicament database, and is a cloud database which electronically marks the historical medication information data in the cloud database by adopting an electronic tag;
medical condition medication database: the medical condition medication information data of the first type of medicine database and/or the second type of medicine database are stored in the medical condition database, and the medical condition medication database is a cloud database which electronically marks the medical condition medication information data in the cloud database by adopting an electronic tag.
The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims (10)
1. An analysis method for drug development by using an intelligent medicine database is characterized by comprising the following steps:
s1, presetting a target stress rule;
setting an electronic target and setting a cloud database comprising medicine and medicinal use data through an electronic tag;
s2, establishing a stress model, and receiving the electronic target and the cloud database through the stress model;
activating the electronic target and the cloud database to obtain a dynamic target and a dynamic drug stimulated scene;
s3, according to the target stress rule, enabling the dynamic target to swim to trigger the dynamic drug stimulated scene;
the electronic tag is used for marking the triggered medicine and medicinal application data in the dynamic medicine stimulated scene;
and S4, acquiring the triggered electronic tag, extracting corresponding medicine and medicinal use data and sending the corresponding medicine and medicinal use data to a medicine research and development center.
2. The method of claim 1, wherein the setting of the cloud database including the drug and pharmaceutical usage data via the electronic tag comprises:
establishing a first-class drug database: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
establishing a second type drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
3. The method of claim 1, wherein the creating a stress model, the receiving the electronic target and the cloud database via the stress model, comprises:
building a stress environment based on the preset target stress rule;
setting a reactor space for accommodating the stress environment;
and establishing a stress model port corresponding to the reactor space.
4. The method as claimed in claim 3, wherein the causing the dynamic target migration to trigger the dynamic drug stimulated scenario according to the target stress rule comprises:
throwing the triggered medicine and medicinal use data electronic tag in the dynamic medicine excited scene into the reactor space through the stress model port;
delivering the dynamic target through the stress model port, wherein the dynamic target triggers a drug with drug property reaction and a medical purpose data electronic tag;
the label triggers the drug and medicinal use data electronic label with drug property reaction.
5. The method according to claim 1 or 4, wherein the cloud database including the drug and pharmaceutical usage data is configured by the electronic tag, and further comprising:
establishing a historical medication database: the historical medication information database stores historical medication information data of the first-class medicament database and/or the second-class medicament database, and is a cloud database which electronically marks the historical medication information data in the cloud database by adopting an electronic tag;
establishing a medical condition medication database: the medical condition medication information data of the first type of medicine database and/or the second type of medicine database are stored in the medical condition database, and the medical condition medication database is a cloud database which electronically marks the medical condition medication information data in the cloud database by adopting an electronic tag.
6. An analysis system for drug development using an intelligent medical database, comprising a targeted stress preparation module, a stress model module, a stress electronic tag acquisition module and an analysis module, wherein:
targeted stress preparation module: for presetting a targeted stress rule; and a cloud database for setting electronic targets and setting data including drugs and medicinal use data by the electronic tags;
a stress model module: the cloud database is used for establishing a stress model, and receiving the electronic target and the cloud database through the stress model; the electronic target and the cloud database are activated to obtain a dynamic target and a dynamic drug stimulated scene;
a stress electronic tag acquisition module: for causing the dynamic target walk to trigger the dynamic drug stimulated scenario according to the targeted stress rule; and an electronic tag for marking the triggered drug and medicinal use data in the dynamic drug stimulated scene;
an analysis module: the electronic tag is used for acquiring the triggered electronic tag, extracting corresponding medicine and medicinal application data and sending the corresponding medicine and medicinal application data to a medicine research and development center.
7. The system of claim 6, wherein the cloud database comprises:
first-class drug databases: the first-class medicine database is a traditional Chinese medicine database, and the traditional Chinese medicine database is a cloud database which electronically marks traditional Chinese medicine and traditional Chinese medicine application data in the cloud database by adopting an electronic tag;
second-class drug database: the second type of medicine database is a western medicine database, and the western medicine database is a cloud database which electronically marks western medicine and western medicine medicinal use data in the cloud database by adopting an electronic tag.
8. The system of claim 6, wherein the stress model module comprises:
a stress environment building platform: the method is used for building a stress environment based on the preset target stress rule;
stress reactor space: for containing the stressful environment;
stress model port: and the electronic tag is used for receiving the triggered medicine and medicinal application data in the dynamic medicine excited scene and putting the electronic tag into a stress reactor space.
9. The system of claim 6, wherein the stress tag module comprises:
electronic tags puts in module: the electronic label is used for throwing the triggered medicine and medicinal use data in the dynamic medicine excited scene into the reactor space through the stress model port; and delivering the dynamic target to the reactor space through the stress model port, wherein the dynamic target triggers a medicine and medicinal use data electronic tag with medicine property reaction;
a marking module: the data electronic tag is used for marking and triggering medicines with medicinal property reactions and medicinal application data.
10. The system of claim 6 or 9, wherein the cloud database further comprises:
historical drug use database: the historical medication information database stores historical medication information data of the first-class medicament database and/or the second-class medicament database, and is a cloud database which electronically marks the historical medication information data in the cloud database by adopting an electronic tag;
medical condition medication database: the medical condition medication information data of the first type of medicine database and/or the second type of medicine database are stored in the medical condition database, and the medical condition medication database is a cloud database which electronically marks the medical condition medication information data in the cloud database by adopting an electronic tag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011020973.3A CN112133381B (en) | 2020-09-24 | 2020-09-24 | Analysis method and system for drug research and development by utilizing intelligent medicine database |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011020973.3A CN112133381B (en) | 2020-09-24 | 2020-09-24 | Analysis method and system for drug research and development by utilizing intelligent medicine database |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112133381A true CN112133381A (en) | 2020-12-25 |
| CN112133381B CN112133381B (en) | 2024-02-23 |
Family
ID=73840085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011020973.3A Active CN112133381B (en) | 2020-09-24 | 2020-09-24 | Analysis method and system for drug research and development by utilizing intelligent medicine database |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112133381B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104981150A (en) * | 2012-12-06 | 2015-10-14 | 马克思-普朗克科学促进协会 | Novel inducible animal models of stress behavior |
| GB201804870D0 (en) * | 2018-03-27 | 2018-05-09 | Innoplexus Ag | System and method for identifying potential targets for pharmaceutical compound |
| CN109545284A (en) * | 2018-10-16 | 2019-03-29 | 中国人民解放军军事科学院军事医学研究院 | Drug integrated information database building method and system based on drug and target information |
| CN111191014A (en) * | 2019-12-26 | 2020-05-22 | 上海科技发展有限公司 | Medicine relocation method, system, terminal and medium |
| CN111489832A (en) * | 2020-04-09 | 2020-08-04 | 南京中爱人工智能与生命科学研究院有限公司 | Visual data processing platform for biological medicine research and development |
| CN111493026A (en) * | 2020-04-30 | 2020-08-07 | 苏州必睿康医药科技有限公司 | Construction method of non-human animal model for type 2 diabetes and application of obtained animal |
| CN111696685A (en) * | 2020-06-04 | 2020-09-22 | 大连理工大学 | Medicine repositioning method for new coronavirus treatment medicine and application thereof |
-
2020
- 2020-09-24 CN CN202011020973.3A patent/CN112133381B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104981150A (en) * | 2012-12-06 | 2015-10-14 | 马克思-普朗克科学促进协会 | Novel inducible animal models of stress behavior |
| GB201804870D0 (en) * | 2018-03-27 | 2018-05-09 | Innoplexus Ag | System and method for identifying potential targets for pharmaceutical compound |
| CN109545284A (en) * | 2018-10-16 | 2019-03-29 | 中国人民解放军军事科学院军事医学研究院 | Drug integrated information database building method and system based on drug and target information |
| CN111191014A (en) * | 2019-12-26 | 2020-05-22 | 上海科技发展有限公司 | Medicine relocation method, system, terminal and medium |
| CN111489832A (en) * | 2020-04-09 | 2020-08-04 | 南京中爱人工智能与生命科学研究院有限公司 | Visual data processing platform for biological medicine research and development |
| CN111493026A (en) * | 2020-04-30 | 2020-08-07 | 苏州必睿康医药科技有限公司 | Construction method of non-human animal model for type 2 diabetes and application of obtained animal |
| CN111696685A (en) * | 2020-06-04 | 2020-09-22 | 大连理工大学 | Medicine repositioning method for new coronavirus treatment medicine and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112133381B (en) | 2024-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2542992B1 (en) | System for data transmission in determination of medicament parameters | |
| da Costa et al. | How thalamus connects to spiny stellate cells in the cat's visual cortex | |
| CN107430641A (en) | Patient care system | |
| CN103093108A (en) | Analysis platform and analysis method of pharmacology of traditional Chinese medicine system | |
| Bolaños et al. | Cost effective raspberry pi-based radio frequency identification tagging of mice suitable for automated in vivo imaging | |
| CN108648830A (en) | A kind of medical service system and method based on cloud platform | |
| Fenrich et al. | Self-directed rehabilitation training intensity thresholds for efficient recovery of skilled forelimb function in rats with cervical spinal cord injury | |
| CN109273098A (en) | A kind of pharmaceutical effectiveness prediction technique and device based on intelligent decision | |
| CN106056173A (en) | Biobank intelligent management system based on RFID and management method thereof | |
| CN107680644A (en) | Intelligent Chinese Traditional Medicine medicine materical crude slice allocates Control management system and method | |
| CN106355013A (en) | Pharmacy medicine dispensing method and system based on internet of things | |
| CN107103199A (en) | A kind of method and device of direction of medication usage | |
| JP2015508204A (en) | Method for tracking physiological samples or pharmaceutical samples | |
| Brock et al. | Development of an inertial motion capture system for kinematic analysis of ski jumping | |
| CN112133381A (en) | Analysis method and system for drug research and development by using intelligent medicine database | |
| CN103065058A (en) | Method and system for evaluating traditional drug toxicity | |
| CN106355014A (en) | Pharmacy medicine distribution method and system based on internet of things | |
| CN109033275A (en) | A kind of prediction technique of the drug regional demand based on association map and neural network | |
| JP2019185827A5 (en) | ||
| CN113782146B (en) | Artificial intelligence-based general medicine recommendation method, device, equipment and medium | |
| CN109360624A (en) | A kind of intelligent clinical pharmacy dispensation apparatus | |
| CN109470346A (en) | A kind of Chinese medicinal formulae intelligent electronic-scale based on Internet of Things | |
| CN112331260B (en) | Pharmaceutical auxiliary material analysis management method and management system | |
| Castro et al. | 2SPD-027 Centralised purchasing as a strategic line for the rationalisation of pharmaceutical expenditure in a regional health service | |
| CN112133380B (en) | Medicine research, development, analysis and application method based on intelligent data model and platform thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Country or region after: China Address after: Room 801 and 802, Building 5, Jieyuan Financial City, No. 55 Andemen Street, Yuhuatai District, Nanjing City, Jiangsu Province, 210012 Applicant after: Nanjing Fantai Digital Technology Research Institute Co.,Ltd. Address before: 6 / F, building 10 (building E), yunmi City, 19 ningshuang Road, Yuhuatai District, Nanjing City, Jiangsu Province, 210041 Applicant before: Nanjing Zhongai artificial intelligence and Life Sciences Research Institute Co.,Ltd. Country or region before: China |
|
| CB02 | Change of applicant information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |